Winfield Associates, Inc. - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Winfield Associates, Inc. ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$9,000
+28.6%
2,0000.0%0.01%
+20.0%
Q4 2014$7,000
-12.5%
2,0000.0%0.01%
-16.7%
Q3 2014$8,000
-27.3%
2,0000.0%0.01%
-25.0%
Q2 2014$11,000
-15.4%
2,0000.0%0.01%
-27.3%
Q1 2014$13,000
+8.3%
2,0000.0%0.01%
+10.0%
Q4 2013$12,0002,0000.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 9,750,000$18,623,0001.60%
DAFNA Capital Management LLC 381,600$729,0000.72%
SENZAR ASSET MANAGEMENT, LLC 1,766,991$3,374,953,0000.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,640,877$8,864,0000.34%
Lyons Wealth Management, LLC. 56,665$110,0000.14%
FEDERATED HERMES, INC. 5,648,920$10,789,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 33,909,459$64,767,0000.02%
Cubist Systematic Strategies, LLC 185,166$354,0000.02%
GAM Holding AG 523,164$997,0000.02%
STEVENS CAPITAL MANAGEMENT LP 191,236$365,0000.02%
View complete list of ARENA PHARMACEUTICALS INC shareholders